A cotton rat (Sigmodon fulviventer) model of human parainfluenza virus type 3 (HPIV-3) infection was used to study patterns of HPIV-3 replication in naive and immune hosts. Growth curves revealed that nasal and pulmonary tissues of naive animals were semi-permissive for virus replication, with amounts of progeny virus proportional to inoculating doses. In naive animals there was a total eclipse in nasal tissues beginning 4 h after inoculation. By contrast, there was only partial eclipse of virus in pulmonary tissues, most pronounced at 1 h after inoculation. immune animals demonstrated a delayed eclipse in pulmonary tissues upon rechallenge. Infection with very low doses of HPIV-3 induced complete protection against high-dose challenge in the absence of systemic neutralizing antibody, suggesting a significant role for other systemic or local immune effectors.
Introduction
Human parainfluenza virus type 3 (HPIV-3) is second only to respiratory syncytial virus (RSV) as a cause of bronchiolitis and pneumonia in children under 2 years of age (Knott et al., / 1994 ). In addition, HPIVs (primarily type 3) have recently been reported to cause more severe lower respiratory disease in children with pre-existing pulmonary abnormalities (Heidemann, 1992) , in hospitalized adult populations (British Public Health Laboratory Service Communicable Disease Surveillance Centre, 1983) , and in both paediatric and adult bone marrow transplant patients (Wendt et aI., 1992) . Murphy et al. (1981) described one species of cotton rat, Sigmodon hispidus, as permissive for infection with HPIV-3, with infected animals developing high pulmonary virus titres, bronchiolitis and pneumonia. S. hispidus has been used to evaluate immunological responses to whole, subunit and recombinant HPIV-3 vaccine preparations (Brideau et aI., 1993 ; Homa et al., 1993; Lehman et al., 1993; Spriggs eta]., 1987; van Wyke Coelingh et al., 1987) .
Previously, we described the pathogenesis of HPIV-3 in Author for correspondence: Martin G. Ottolini.
Fax + 1 301 2.95 3938. e-mail Ottolini@USUHSB.USUHS.MIL two species of cotton rat, S. hispidus and S. fulviventer (Porter et aI., 1991) . Both displayed high levels of intranasal and intrapulmonary replication of HPIV-3, and developed serum neutralizing antibody after receiving a large inoculum of virus. Both species displayed pulmonary histopathological changes, with S. hispidus developing moderately severe bronchiolitis, while S. fulviventer developed extensive interstitial pneumonia. Previous work left several important questions unanswered. A key concern for researchers using this animal model would be knowledge of the degree of permissiveness of virus replication in nasal and pulmonary tissues. If replication were semipermissive, with amounts of progeny virus recovered during peak virus replication directly proportional to inoculating dose, this would allow investigators control over the degree of experimental infection induced. A fully permissive pattern of replication, in which virus replication would reach similar peak titres regardless of inoculating dose, would indicate an inability to control this variable. We now report the degree of permissiveness of virus replication, and quantitative and temporal aspects of the immune response to HPIV-3.
Hethods
• Animals. Cotton rats (Sigmodon fulviventer, SIF/Vsi) were obtained from a breeding colony maintained at Virion Systems Incorporated, '3 c. Rockville, Md., USA. Animals were seronegative for adventitious paramyxoviruses, RSV, and other rodent pathogens.
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[] Virus. A large pool of HPIV-3 grown in LLC-MK2 cells (ATCC), with a titre of approximately 10 e~ p.f.u./ml, was used in all experiments.
[] Experimental protocol. Cotton rats were lightly anaesthetized with methoxyfluorane inhalation and inoculated with neat or 10-fold dilutions of HPIV-3. All inoculations (priming and challenge) were intranasal, using 0"I ml of virus suspension. Animals were sacrificed by CO2 asphyxiation at intervals following inoculation. For virus titration, nasal and lung tissues were homogenized in I0 parts (w/v) of Hanks' balanced salt solution (BSS) supplemented with 0-218 M-sucrose--4"9 mM-glutamat¢~-3"8 mM-KH2PO~-7"2 mM-K2HPO 4, to increase stability of the virus. Following homogenization, samples were centrifuged at 770 8, 4 °C for 10 min. Supematant suspensions were stored at -70 °C until assayed.
[] Virus titration. Virus titres for HPIV-3 were determined by plaque assay on MA 104 African green monkey kidney cell monolayers, as previously described (Porter et al., 1991) . Virus titres are expressed as the geometric mean of individual titres (p.f.u. per gram of tissue, plus or minus the standard error) for each group. The lowest level of virus replication detectable was 102 p.f.u, per gram of tissue for lungs and nose.
[] Antibody assays. Serum neutralizing antibody against HPIV-3 was measured by a 60% plaque reduction neutralization assay on MA 104 monolayers, as previously reported (Porter ct al., I991) . Results are expressed as the geometric mean antibody titre for each group.
Results

Dose-dependent growth curves
Five groups of cotton rats were inoculated intranasally with 0"1 ml of HPIV-3 in tenfold dilutions, resulting in infectious doses ranging from 105.5 p.f.u, to 1015 p.f.u. Inoculating solutions were concurrently sampled for virus titration by plaque assay as described above, to verify accuracy of the infecting dose. Six animals were sacrificed from each group on days I through 8 after infection, for determination of lung and nasal tissue virus titres. HPIV-3 replication in the lungs was semi-permissive, with virus replication proportional to inoculating dose (Fig. la) . Also, the peak of virus replication in lung tissues occurred later with lower inoculating doses (on day 6 for the 1015 inoculation vs. day 3 for I0 ~5 p.f.u.), and the duration of infection was prolonged by I day with the lowest inoculating dose. A similar pattern of semi-permissiveness was shown in nasal tissues (Fig. I b) .
Influence of the immune response on virus recovery over time
The immune response to naive animals with that observed in immune (i.e. previousIy infected) animals at sequential time intervals after experimental inoculation with HPIV-3. Initially, immune animals were infected intranasally with 10 s5 p.f.u, of HPIV-3. Two weeks later, these animals, along with an age-matched group of naive 5 animals, were challenged with 10 s'5 p.f.u, of HPIV-3 intra-~ nasally. In multiple experiments, several animals from each group were sacrificed at 5 and 30 rain, 1, 2, 4, 8, 12, 16, 20, 24 and 96 h after challenge for determination of pulmonary and -= 4 nasal virus titres as discussed above (Fig. 2a and Fig. 2 b are .~ composites of these series). In naive animals the eclipse phase lasted from 4 to 12 h in nasal tissue, and from 1 to 12 h in o ~ pulmonary tissue. In immune animals, virus was cleared rapidly 3 in nasal tissues, with no infectious virus recovered by I h. Virus clearance in pulmonary tissues was slower, requiring 4 h. An unexpected phenomenon was repeatedly observed to _<2 occur in each experiment in the lungs of immune animals at the I h time-point (Fig. 2 a) . During every experiment pulmonary titres in immune animals were between five-and tenfold higher than in naive animals, at or near this time-point.
Dose-dependent immune response
Dose-dependent aspects of the immune response to HPIV-3 in S. fu]viventer were examined by initially infecting six groups of animals with tenfold dilutions of HPIV-3 intranasally. These doses ranged from 10 ss to 10 1.s p.f.u, per animal, with accuracy of doses confirmed by concurrent titration of inoculating suspensions as described above. After a 3 week in~ervaI, these six groups plus a group of naive control animals were challenged with 10 '~5 p.f.u, of HPIV-3 intranasally. Animals were bled for determination of serum neutralizing antibody prior to challenge. Four days after challenge, animals fulviventer. Cotton rats were initially inoculated intranasally with graded doses of HPIV-3 ranging from 10 -1 5 to 10 3.5 p.f.u, of virus. After 3 weeks, these animals along with a group of naive control animals were challenged with 10 5.5 p.f.u, of HPIV-3, and sacrificed 4 days postchallenge. Each bar represents the geometric mean virus titre (Ioglo) for a group of eight animals, and standard errors are shown. The serum neutralizing antibody titres against HPIV-3 (reciprocal of the geometric mean) at the time of challenge are shown above the bars.
were sacrificed for determination of pulmonary and nasal virus titres, as shown in Fig. 3 . Animals initially infected with I0 ~s and 102s p.f.u, of HPIV-3 had moderate reciprocal neutralizing antibody titre against HPIV-3 (214 and 163, respectively), and showed complete protection against reinfection in both the lungs and the nose. Complete protection in both tissues was also observed after initial infecting doses of 1"5 and 0"5 log p.f.u, of HPIV-3, despite the absence of demonstrable neutralizing antibody in most animals, Complete resistance to pulmonary, but not nasal virus replication was seen in animals previously infected with as little as I0 -0.5 p.f.u, of virus (i.e. less than i p.f.u.), in which no neutralizing antibody was detected.
Discussion
Three aspects of HPIV-3 pathogenesis are illuminated by the current report. The first is that HPIV-3 infection in the cotton rat is semi-permissive, meaning that the peak virus titre is proportional to the challenge dose of virus. This is in contrast to a fully permissive model, such as pneumonia virus of mice in its natural host, wherein the peak titre is not dependent upon challenge dose (Horsfall & Ginsberg, 195I; Ginsberg & Horsfall, 1952) , although larger doses result in peak titres sooner than with smaller doses. For experimental purposes, semi-permissiveness offers the investigator the option of increasing or decreasing the degree of virus replication and related histopathological changes, a critical factor in our recent demonstration of the efficacy of passive immunoprophylactic regimens against physiological (i.e. lowdose) challenge with RSV (Sami et al., 1995) . Evaluation of such regimens would have been obscured if the degree of challenge infection could not have been controlled.
The second aspect of this model deals with the kinetics of virus replication in naive and immune animals. The growth curve of nasal infection yielded no surprises, with an eclipse phase in naive animals beginning approximately 4 h after challenge and the appearance of progeny virus first occurring at 16 h. The faster disappearance and absence of progeny virus seen in immune animals also was not surprising, particularly in light of the fact that these animals received an initial infection with a high dose of HPIV-3 (105.5 p.f.u.) which in the 'dosedependent immune response' experiments led to solid protection against reinfection in pulmonary and nasal tissues, with concurrent development of high levels of circulating neutralizing antibody.
The kinetics of pulmonary infection, however, were not entirely expected. Naive animals did not demonstrate the total eclipse of infectious virus detected in nasal tissues. While the exact mechanism underlying this observation is not known, we propose that following intranasal inoculation virus quickly passes over nasal tissues, with a portion being adsorbed to the epithelium, while the rest probably 'pools' in the terminus of the respiratory tree and may not have uniform access to cell receptors, leading to the continued presence of residual infectious virus from the initial inoculum at the same time as progeny virus begins to appear. While a similar 'reservoir' effect might also apply to the kinetics in lungs of immune animals, where the eclipse period is longer than in the nose, a remarkable phenomenon occurred within the first hour wherein pulmonary titres were consistently higher in immune than in naive animals. The recovery of lower nasal titres and higher pulmonary titres in the first hour after rechallenge of immune animals may reflect the effects of specific mechanisms of immunity, but may also be influenced by tissue alterations persisting after the initial infection, which might contribute to the different kinetics of virus clearance.
The third and most compelling finding to emerge from this report is the extraordinary sensitivity of the cotton rat to HPIV-3, wherein fewer than 10 p.f,u, of virus can effectively immunize an animal against subsequent high-dose (10 s5 p.f.u.) challenge. Moreover, complete resistance occurs both in nasal and in pulmonary tissues in the absence of detectable serum neutralizing antibody, suggesting a significant role for other mediators such as cell-mediated immunity or components of mucosal immunity. This documentation of 'immunity without antibody' has significant implications for vaccinology. First, it is quite possible that a successful HPIV-3 vaccine might induce little or no serum neutralizing antibody. While it is also possible that an effective HPIV-3 vaccine might induce a strong neutralizing antibody response, over-reliance on the neutralization test might result in rejection of an otherwise promising vaccine. We suggest, therefore, that the in vitro correlates of vaccine efficacy must include other parameters in addition to the in vitro neutralization test.
The second implication is that epidemiological and vaccine studies which have assumed that seronegativity (i.e. the absence of measurable serum neutralizing antibody) signified no prior interaction between the targeted virus and host might be flawed. Two scenarios might serve to illustrate this point. The first would be a sub-clinical infection wherein either the small size of the inoculating dose or the genetic constitution of the host resulted in low or no neutralizing antibody response, yet stimulated other immunological effectors. Recent studies in this laboratory using a small priming dose of RSV in cotton rats support this possibility (Johnson et aI., 1996) . The second would be an infection in an infant possessing sufficient maternal antibody to dampen or block the serum neutralizing antibody response in the infant, while not interfering with the specific response of other immunological effectors. We have noted this very phenomenon in cotton rats treated with passive antibody shortly after infection, which developed solid nasal and pulmonary immunity in the complete absence of neutralizing serum antibody (Prince et al., 1985) . Thus, the assumption that infants seronegative for paramyxovirus antibody are immunologically naive is fundamentally flawed, and alternative markers of immunological naivet6 should be considered.
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